Alert detail

LCD L38333: MolDX: Blood Product Molecular Antigen Typing — Noridian

Policy ID: LCD-L38333Specialty: Infectious Disease / MicrobiologyAdded: 6/5/2026Effective: November 7, 2024lcd
High

What changed

New MolDX guidelines affect blood product billing.

Who’s affected: Infectious Disease / Microbiology billing teams · Effective: November 7, 2024

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 37 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Infectious Disease / Microbiology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Not ready to subscribe?

Get the free weekly reimbursement brief for Infectious Disease / Microbiology— the week’s changes and deadlines, delivered to your inbox. No account required.

LCD L38333: MolDX: Blood Product Molecular Antigen Typing — Noridian